Clinical trial for Type 1 Diabetes Mellitus
Official title Pediatric Artificial Intelligence for Retinopathy Screening in Children With Type 1 Diabetes
ClinicalTrials.gov ID: NCT07149142
What this study is testing
- What it's testing
- This study checks if computer software can find early signs of eye damage as well as standard eye exams. It also looks at how common these eye issues are in children with well-controlled diabetes.
- Who it's for
- Children and young adults with Type 1 diabetes who are in good control of their condition.
- What's involved
- Participants will have photos taken of the back of their eyes. These photos will be checked by AI software, a doctor, and a special eye scanner. People over 18 will also have a test to check for nerve damage.
- Time commitment
- The study involves a single visit for eye exams and questionnaires.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 11 to 19
You may be able to join if
- Type 1 diabetes diagnosed according to the ADA criteria
- Age over 11.0 years or duration of diabetes over 2 years
- Signed written informed consent by both the CwD and their parent/caregiver
You likely can't join if
- Unwillingness to sign a written informed consent by both the CwD and their parent/caregiver
The study team makes the final eligibility decision.
Where it is enrolling
- Prague, Prague 5, Czechia
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part, but confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 11 years to 19 years. The study team makes the final eligibility decision.
Where is this trial taking place?
This study is enrolling now at Prague, Prague 5, Czechia. Enter your location above to see the nearest enrolling site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool that is independent of the study sponsor. Details come from ClinicalTrials.gov. The study team decides eligibility, and your own doctor gives medical advice.